Using hyperpolarized 129Xe MRI to assess lung function in healthy individuals and those with lung diseases
Official title: Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Run by University of Kansas Medical Center · NCT04624490 · Data updated 2026-11-12
This study is testing a special type of MRI using hyperpolarized gas to see how well it can check lung function in both healthy people and those with lung diseases like asthma and COPD.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 3 Years and up |
| Sex | All |
| Enrollment | 260 (estimated) |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 1 site (Kansas City, Kansas) |
| Status | Recruiting |
| Started | November 2, 2020 |
| Main results expected | October 26, 2028 |
| Study ends | October 26, 2028 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT04624490 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18-80 with diagnosed pulmonary dysfunction or healthy individuals without any pulmonary conditions.
✕Probably not a fit
Patients who are pregnant, have contraindications for MRI, or have severe cognitive deficits may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of hyperpolarized (HP) 129Xe gas MRI for assessing regional lung function in both healthy volunteers and individuals diagnosed with pulmonary diseases such as asthma, COPD, and cystic fibrosis. Approximately 160 subjects with pulmonary conditions and 100 healthy controls will participate in this open-label study. Participants will undergo imaging on an outpatient basis, receiving multiple doses of HP 129Xe gas, along with conventional MRI scans to provide anatomical context. The study will take place at the University of Kansas Medical Center.
Why it matters
Potential benefit: If successful, this study could enhance the diagnostic capabilities for assessing lung function in patients with various pulmonary diseases.
How similar studies have gone: While the use of hyperpolarized gas MRI is a relatively novel approach, preliminary studies have shown promise in assessing lung function, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Healthy Volunteers: * Subject has no diagnosed pulmonary conditions * Ability to read and understand English or Spanish Subjects with Lung Disease: * Subject has a diagnosis of pulmonary dysfunction made by a physician * No acute worsening of pulmonary function in the past 30 days * Ability to read and understand English or Spanish Exclusion Criteria: * MRI is contraindicated based on responses to MRI screening questionnaire * Subject is pregnant or lactating * Subject does not fit into 129Xe vest coil used for MRI * Subject cannot hold his/her breath for 15-16 seconds * Subject deemed unlikely to be able to comply with instructions during imaging * Oxygen saturation \<88% on room air or with supplemental oxygen * Cognitive deficits that preclude ability to provide consent * Institutionalization
Where it's running
-
University of Kansas Medical Center
Kansas City, Kansas, United States Recruiting
Study contacts
- Principal investigator: Peter Niedbalski, PHD — University of Kansas Medical Center
- Study coordinator: Cristal Monge
- Email: chernandez@kumc.edu
- Phone: 913-945-9399
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using smartphone technology to evaluate airway conditions
This study is testing if smartphone technology can help check lung health and spot breathing problems in both healthy people and those with asthma or COPD.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
Right‑side heart response to exercise in people with COPD
This project will test how the right side of the heart responds to moderate and high‑intensity exercise in adults 40 and older with COPD and whether a targeted moderate‑intensity cycling program can improve that response.
-
Home exercise for people with pulmonary hypertension and ILD
A home-based exercise program is tested to see if people with pulmonary hypertension related to interstitial lung disease can improve walking ability and daily function over 16 weeks.
-
Asthma and COPD among workers at Navanakorn Industrial Zone in Thailand
This project will test how common asthma and COPD are among adult workers at the Navanakorn Industrial Zone by asking about breathing symptoms and doing lung function (spirometry) tests.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.